[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100434814":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":30,"responsibleParty":172,"collaborators":174,"id":178,"slug":179,"hasResults":180,"nctId":181,"briefTitle":182,"officialTitle":182,"acronym":183,"eligibilityCriteria":184,"healthyVolunteers":180,"sex":185,"minAge":186,"maxAge":11,"enrollmentInfo":187,"targetDuration":11,"studyType":190,"phases":191,"briefSummary":193,"conditions":194,"keywords":199,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":203,"lastUpdatePostDateStruct":204,"startDateStruct":207,"completionDateStruct":209,"leadSponsor":211,"locationsCount":212},{"fullName":5,"class":6},"University Hospital, Angers","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CALRSUIVI cohort","EXPERIMENTAL",null,[13],"Biological: CALR allele burden quantification",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"BIOLOGICAL","CALR allele burden quantification","* DNA extraction from blood sample for CALR mutation quantification (fragment analysis)\n* at diagnosis and follow-up (inclusion period: 3 years)\n* max 1 sample\u002Fyear\n* secondary outcome: mutational landscape by Next Generation Sequencing (NGS) analysis at diagnosis",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Laurane COTTIN, Doctor","CONTACT","+33 2 41 35 53 53","Laurane.Cottin@chu-angers.fr",{"name":27,"role":23,"phone":28,"phoneExt":11,"email":29},"Emma BLANCHET","+33 2 41 35 63 38","EmBlanchet@chu-angers.fr",[31,46,60,74,88,102,116,130,144,158],{"facility":32,"status":33,"city":34,"state":11,"zip":11,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"CHU Angers","RECRUITING","Angers","France","FR",{"type":38,"coordinates":39},"Point",[40,41],-0.55202,47.47156,{"lat":41,"lon":40},[44],{"name":45,"role":23,"phone":11,"phoneExt":11,"email":11},"Laurane COTTIN, Dr",{"facility":47,"status":33,"city":48,"state":11,"zip":49,"country":35,"countryCode":36,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Chu Bordeaux","Bordeaux","33604",{"type":38,"coordinates":51},[52,53],-0.58046,44.84124,{"lat":53,"lon":52},[56],{"name":57,"role":23,"phone":58,"phoneExt":11,"email":59},"Olivier MANSIER, DOCTOR","+335 57 65 64 78","olivier.mansier@u-bordeaux.fr",{"facility":61,"status":33,"city":62,"state":11,"zip":63,"country":35,"countryCode":36,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Chu Brest","Brest","29200",{"type":38,"coordinates":65},[66,67],-4.48628,48.39029,{"lat":67,"lon":66},[70],{"name":71,"role":23,"phone":72,"phoneExt":11,"email":73},"ERIC LIPPERT, PROFESSOR","+332 98 34 70 33","eric.lippert@chu-brest.fr",{"facility":75,"status":33,"city":76,"state":11,"zip":77,"country":35,"countryCode":36,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Ch Cholet","Cholet","49300",{"type":38,"coordinates":79},[80,81],-0.87974,47.05893,{"lat":81,"lon":80},[84],{"name":85,"role":23,"phone":86,"phoneExt":11,"email":87},"CHARLES BESCOND, DOCTOR","+332 41 49 68 07","alain.zannetti@ch-cholet.fr",{"facility":89,"status":33,"city":90,"state":11,"zip":91,"country":35,"countryCode":36,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Ch Le Mans","Le Mans","72037",{"type":38,"coordinates":93},[94,95],0.20251,48.0021,{"lat":95,"lon":94},[98],{"name":99,"role":23,"phone":100,"phoneExt":11,"email":101},"KAMEL LARIBI, DOCTOR","+332 43 43 43 60","klaribi@ch-lemans.fr",{"facility":103,"status":33,"city":104,"state":11,"zip":105,"country":35,"countryCode":36,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Ch Morlaix","Morlaix","29672",{"type":38,"coordinates":107},[108,109],-3.82792,48.57784,{"lat":109,"lon":108},[112],{"name":113,"role":23,"phone":114,"phoneExt":11,"email":115},"CHRISTOPHE NICOL, DOCTOR","+332 98 62 60 38","CNicol@ch-morlaix.fr",{"facility":117,"status":33,"city":118,"state":11,"zip":119,"country":35,"countryCode":36,"cosmosGeoPoint":120,"geoPoint":124,"contacts":125},"AP-HP Henri Mondor","Paris","94010",{"type":38,"coordinates":121},[122,123],2.3488,48.85341,{"lat":123,"lon":122},[126],{"name":127,"role":23,"phone":128,"phoneExt":11,"email":129},"Lydia ROY, DOCTOR","+331 49 81 20 57","lydia.roy@aphp.fr",{"facility":131,"status":33,"city":132,"state":11,"zip":133,"country":35,"countryCode":36,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Chu Poitiers","Poitiers","86021",{"type":38,"coordinates":135},[136,137],0.34348,46.58261,{"lat":137,"lon":136},[140],{"name":141,"role":23,"phone":142,"phoneExt":11,"email":143},"Jose Miguel TORREGROSA-DIAZ, DOCTOR","+335 49 44 44 44","jose-miguel.torregrosa-diaz@inserm.eu",{"facility":145,"status":33,"city":146,"state":11,"zip":147,"country":35,"countryCode":36,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"Ch Quimper","Quimper","29107",{"type":38,"coordinates":149},[150,151],-4.09795,47.99597,{"lat":151,"lon":150},[154],{"name":155,"role":23,"phone":156,"phoneExt":11,"email":157},"Lenaig LE CLECH, DOCTOR","+332 98 52 61 50","l.leclech@ch-cornouaille.fr",{"facility":159,"status":33,"city":160,"state":11,"zip":161,"country":35,"countryCode":36,"cosmosGeoPoint":162,"geoPoint":166,"contacts":167},"Chu Tours","Tours","37000",{"type":38,"coordinates":163},[164,165],0.70398,47.39484,{"lat":165,"lon":164},[168],{"name":169,"role":23,"phone":170,"phoneExt":11,"email":171},"Olivier HERAULT, PROFESSOR","+332 47 47 47 21","olivier.herault@univ-tours.fr",{"type":173,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[175],{"name":176,"class":177},"Ligue contre le cancer, France","OTHER","100434814","interest-of-calr-allele-burden-in-diagnosis-and-follow-up-of-patients-with-calr-mutated-myeloproliferative-syndromes-calrsuivi-100434814",false,"NCT04942080","Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)","CALRSUIVI","Inclusion Criteria:\n\n* adults (age ≥18 years),\n* affiliated to the national social security system,\n* with CALR mutated myeloproliferative neoplasm diagnosed between 2006 - 2020,\n* for which at least one sample is available at the time of diagnosis or before cytoreductive treatment,\n* who signed the consent to participate in the study,\n* included, or consenting to be included, in the national clinical-biological database of France Intergroupe Syndrome Myéloprolifératifs (FIM).\n\nExclusion Criteria:\n\n* patient with another active hematological disease or cancer at the time of diagnosis,\n* person subject to legal protection scheme or incapable of giving consent.","ALL","18 Years",{"count":188,"type":189},260,"ESTIMATED","INTERVENTIONAL",[192],"NA","Prospective study to evaluate the relevance of CALR allele burden monitoring as a molecular marker of disease progression.",[195,196,197,198],"Myeloproliferative Neoplasm","Essential Thrombocythemia","Primary Myelofibrosis, Prefibrotic Stage","Primary Myelofibrosis, Fibrotic Stage",[200,195,196,201,202],"CALR","Primary Myelofibrosis","Thrombocytosis","2026-03-05",{"date":205,"type":206},"2026-03-06","ACTUAL",{"date":208,"type":206},"2021-10-28",{"date":210,"type":189},"2030-04-28",{"name":5,"class":6},10]